Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).
Background:
Cross transmission via skin contact and environmental media is the main route for common outbreak of health care-associated infection which more likely to be improved or prevented by infection control program. Silver Knight uses silver ions to disrupt the normal enzymatic activities of bacteria for reducing microbial growth within, and on, the surface of the breathing systems. It functions as a safe, quick and effective catalyst to deactivate pathogenic bacteria and prevent their proliferation. However, there was no study comparing the standard ventilator circuit with Silver Knight. This study focuses on the effectiveness of antimicrobial breathing system in MDRO which including carbapenem-resistant, vancomycin-resistant and multi-drug resistant.
Study Design:
This is a prospective, randomized study in a single hospital in the intensive care unit.
Methods:
In this study, we conduct a cluster-randomized crossover, single-centre trial. There are two groups:
Effect:
We expect the antimicrobial breathing system could be more effectively than the standard ventilator circuit. The policy related to current ventilator circuit will be revised according to the results of this study.
Key words:
Antimicrobial Breathing system, ventilator circuits, multidrug-resistant organisms (MDRO)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SilverKnight group | Experimental | Silver Knight is an anti-microbial additive that uses silver ions to disrupt the normal enzymatic activities of bacteria |
|
| Control group | No Intervention | The control group uses standard ventilator circuits. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Silver Knight | Device | Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including:
|
| Measure | Description | Time Frame |
|---|---|---|
| bacterial contamination | comparison of the two ventilator systems | one month |
| Measure | Description | Time Frame |
|---|---|---|
| bacterial detection rate | comparison of the two ventilator systems | one month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wen-Lun Liu, MD | Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fu Jen Catholic University Hospital, Fu Jen Catholic University | New Taipei City | 24352 | Taiwan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27714706 | Background | Zilahi G, Artigas A, Martin-Loeches I. What's new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016 Dec;6(1):96. doi: 10.1186/s13613-016-0199-4. Epub 2016 Oct 6. | |
| 40052538 | Derived | Chao KY, Liu WL, Chen CY, Su CH, Yang SH, Huang YT. Bacterial Colonization of Silver-Additive Ventilator Circuit in Patients Receiving Mechanical Ventilation: A Randomized Controlled Trial. Clin Respir J. 2025 Mar;19(3):e70058. doi: 10.1111/crj.70058. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, we conduct a cluster-randomized crossover, multicenter trial.There are two groups:
Not provided
Not provided
Not provided
Not provided
|